Stay updated on RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedA new Publications entry has been added, listing authors and a NEJM 2026 article on Daraxonrasib for previously treated RAS-mutant cancers. This update connects the study to recent related research and provides readers with a current reference.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a new version of the study record on the ClinicalTrials.gov page. The update reflects page-level versioning rather than changes to the study data presented.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision tag on the page updated from v3.6.4 to v3.6.5. This indicates a minor update to the page content or underlying software.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page footer revision label was updated from v3.6.3 to v3.6.4, indicating a minor system update to the page. This does not reflect changes to the study content or visible information.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page's revision label updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a new deployment of the page. This change represents an internal version update rather than a modification to study content.SummaryDifference0.0%

- Check75 days agoChange DetectedA new site revision tag (v3.6.2) has been introduced, replacing the previous revision (v3.6.0). This indicates a minor platform update without altering the study details or primary content.SummaryDifference0.0%

Stay in the know with updates to RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.